AB Science S.A. (OTCMKTS:ABSCF) Short Interest Down 95.0% in April

AB Science S.A. (OTCMKTS:ABSCF) was the target of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 400 shares, a decline of 95.0% from the March 31st total of 8,000 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

AB Science Price Performance

Shares of OTCMKTS:ABSCF opened at $2.70 on Friday. AB Science has a fifty-two week low of $2.55 and a fifty-two week high of $3.84. The business has a 50-day simple moving average of $3.21 and a two-hundred day simple moving average of $4.03.

AB Science Company Profile

AB Science SA, a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19.